Showing results (531-540 of 610) with videos related to

Sort By:
Pageof 61
Journal of Medical Genetics|May 3, 2005
Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathyT Rossenbacker, E Schollen, C Kuipéri, et al.
EJNMMI Research|January 24, 2014
Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CTMartin W Huellner, Timothy D Collen, Philipp Gut, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2006
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritisM Van de Wouwer, S Plaisance, A De Vriese, et al.
Blood|February 9, 2000
Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functionsE M Conway, S Pollefeyt, J Cornelissen, et al.
Circulation|March 1, 1984
Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technologyF Van de Werf, S R Bergmann, K A Fox, et al.
Circulation|February 1, 1986
Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusionH K Gold, R C Leinbach, H D Garabedian, et al.
Thrombosis and Haemostasis|June 1, 1992
G4120, an Arg-Gly-Asp containing pentapeptide, enhances arterial eversion graft recanalization with recombinant tissue-type plasminogen activator in dogsH R Lu, H K Gold, Z Wu, et al.
Radiology|April 1, 1989
Thrombus imaging with an I-123-labeled F(ab')2 fragment of an anti-human fibrin monoclonal antibody in a rabbit modelY Hashimoto, J M Stassen, B Leclef, et al.
Klinische Wochenschrift|January 1, 1988
[Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]M Verstraete, M Bory, D Collen, et al.
Blood|May 11, 1999
Structure-function analyses of thrombomodulin by gene-targeting in mice: the cytoplasmic domain is not required for normal fetal developmentE M Conway, S Pollefeyt, J Cornelissen, et al.
Pageof 61